BSN set for blowout with tightened OID, Aussie dollar success
Strong demand from banks and funds has allowed bookrunners on the senior loans backing EQT’s buy-out of German bandages maker BSN Medical to tighten the yield on the term loan ‘B’ in the borrower’s favour and increase the size of the committed acquisition facility by €50m — taking the total amount of senior loans to €915m.
As a large, well performing company with an existing syndicate and in a strong sector and jurisdiction, BSN had long been expected to be a blowout. Some loan investors had expressed concern about BSN’s leverage when the deal was launched, saying syndication may not be so straightforward. But
...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Or sign up for a trial to gain full access to the entire site for a limited period.
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
